SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000814133-23-000052
Filing Date
2023-02-10
Accepted
2023-02-10 13:46:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 espr223.txt SC 13G/A 2463
  Complete submission text file 0000814133-23-000052.txt   4057
Mailing Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108
Business Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108 8015330777
WASATCH ADVISORS INC (Filed by) CIK: 0000814133 (see all company filings)

IRS No.: 870319391 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Subject) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87536 | Film No.: 23610270
SIC: 2834 Pharmaceutical Preparations